| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
56,296,000 |
| Market
Cap: |
244.32(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.07 - $5.88 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF™, to create a variety of protein therapeutics initially for cancer and autoimmune disorders. Co.'s two product candidates are wholly owned: STRO-001, an antibody-drug conjugates (ADC) directed against CD74, for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
12,185 |
39,226 |
39,226 |
| Total Sell Value |
$0 |
$60,925 |
$186,802 |
$186,802 |
| Total People Sold |
0 |
1 |
2 |
2 |
| Total Sell Transactions |
0 |
1 |
3 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
• – – |
2021-09-24 |
4 |
D |
$19.23 |
$73,266 |
D/D |
(3,810) |
66,496 |
|
- |
|
| Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
• – – |
2021-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,019 |
70,306 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2021-09-24 |
4 |
D |
$19.23 |
$57,228 |
D/D |
(2,976) |
26,492 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2021-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,609 |
29,468 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2021-08-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,270 |
|
-18% |
|
| Newell William J |
CEO |
• • – |
2021-07-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
104,662 |
104,662 |
|
- |
|
| Newell William J |
CEO |
• • – |
2021-07-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
104,662 |
80,687 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2021-01-29 |
4 |
D |
$22.15 |
$69,706 |
D/D |
(3,147) |
20,719 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2021-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
23,866 |
|
- |
|
| Newell William J |
CEO |
• • – |
2021-01-29 |
4 |
D |
$22.15 |
$156,401 |
D/D |
(7,061) |
185,349 |
|
- |
|
| Newell William J |
CEO |
• • – |
2021-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,750 |
192,410 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2021-01-29 |
4 |
D |
$22.15 |
$47,091 |
D/D |
(2,126) |
14,200 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2021-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
16,326 |
|
- |
|
| Hallam Trevor |
Chief Scientific Officer |
• – – |
2021-01-29 |
4 |
D |
$22.15 |
$46,072 |
D/D |
(2,080) |
59,287 |
|
- |
|
| Hallam Trevor |
Chief Scientific Officer |
• – – |
2021-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
61,367 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2021-01-29 |
4 |
D |
$22.15 |
$40,867 |
D/D |
(1,845) |
13,920 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2021-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
15,765 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2021-01-29 |
4 |
D |
$22.15 |
$46,670 |
D/D |
(2,107) |
20,859 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2021-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
22,966 |
|
- |
|
| Hallam Trevor |
Chief Scientific Officer |
• – – |
2021-01-26 |
4 |
AS |
$25.68 |
$61,528 |
D/D |
(2,393) |
56,117 |
|
-23% |
|
| Hallam Trevor |
Chief Scientific Officer |
• – – |
2021-01-26 |
4 |
OE |
$4.36 |
$10,433 |
D/D |
2,393 |
58,510 |
|
- |
|
| Petree Daniel H |
Director |
– • – |
2021-01-26 |
4 |
OE |
$4.36 |
$18,016 |
D/D |
4,132 |
7,988 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2021-01-19 |
4 |
OE |
$4.36 |
$7,203 |
D/D |
1,652 |
15,616 |
|
- |
|
| Hallam Trevor |
Chief Scientific Officer |
• – – |
2021-01-14 |
4 |
OE |
$4.36 |
$84,606 |
D/D |
19,405 |
56,117 |
|
- |
|
| Hallam Trevor |
Chief Scientific Officer |
• – – |
2020-12-28 |
4 |
AS |
$22.37 |
$53,530 |
D/D |
(2,393) |
36,712 |
|
-12% |
|
219 Records found
|
|
Page 6 of 9 |
|
|
0.11 (2.6%) 
